Origins of the malignant clone in typical Waldenstrom's macroglobulinemia
- PMID: 12720123
- DOI: 10.1053/sonc.2003.50072
Origins of the malignant clone in typical Waldenstrom's macroglobulinemia
Abstract
Histopathology and phenotypic considerations in IgM-secreting B-cell tumors allow distinction between different diseases, but insight into pathogenesis is restricted. Here, variable region (V) gene analysis can complement classification but, more importantly, can also reveal disease origins and clonal history. We used V(H) gene analysis to probe origins in Waldenstrom's macroglobulinemia (WM), and contrasted these with the less malignant counterpart, IgM-secreting monoclonal gammopathy of undetermined significance (MGUS). Limited data on WM sequences had previously shown evidence for somatic mutation, but with conflicting analysis of intraclonal variation in tumor sequences. To further the investigation, we analyzed seven cases of WM and compared these with three cases of IgM MGUS. In both diseases, V(H) genes were somatically mutated with no evidence of intraclonal variation, even at the MGUS stage. A sensitive V(H) gene-probe assay revealed no evidence for isotype switch transcripts in any of the WM and IgM MGUS cases. These findings reveal an origin of WM and IgM MGUS from a IgM cell, which transforms after cessation of somatic mutation but without initiating switch events. In contrast, IgM-secreting multiple myeloma arises at a later stage in differentiation, when isotype switch mechanisms have been engaged.
Copyright 2003 Elsevier Inc. All rights reserved.
Similar articles
-
The malignant clone in Waldenstrom's macroglobulinemia.Semin Oncol. 2003 Apr;30(2):132-5. doi: 10.1053/sonc.2003.50061. Semin Oncol. 2003. PMID: 12720122
-
Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.Clin Lymphoma Myeloma. 2006 Jul;7(1):70-2. doi: 10.3816/CLM.2006.n.042. Clin Lymphoma Myeloma. 2006. PMID: 16879773
-
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events.Blood. 2002 Aug 15;100(4):1505-7. Blood. 2002. PMID: 12149241
-
Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?Clin Lymphoma. 2005 Mar;5(4):217-9. doi: 10.3816/clm.2005.n.002. Clin Lymphoma. 2005. PMID: 15794851 Review.
-
Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.Semin Oncol. 2003 Apr;30(2):110-5. doi: 10.1053/sonc.2003.50082. Semin Oncol. 2003. PMID: 12720118 Review.
Cited by
-
Molecular pathogenesis of Waldenstrom's macroglobulinemia.Haematologica. 2012 Sep;97(9):1281-90. doi: 10.3324/haematol.2012.068478. Epub 2012 Jul 6. Haematologica. 2012. PMID: 22773606 Free PMC article. Review.
-
Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.ISRN Hematol. 2013 Sep 9;2013:815325. doi: 10.1155/2013/815325. ISRN Hematol. 2013. PMID: 24106612 Free PMC article. Review.
-
TCL1 expression patterns in Waldenström macroglobulinemia.Mod Pathol. 2016 Jan;29(1):83-8. doi: 10.1038/modpathol.2015.122. Epub 2015 Oct 23. Mod Pathol. 2016. PMID: 26493619
-
B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS.Front Immunol. 2020 Dec 1;11:602868. doi: 10.3389/fimmu.2020.602868. eCollection 2020. Front Immunol. 2020. PMID: 33343574 Free PMC article.
-
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.Blood Cancer Discov. 2021 Sep 1;2(6):600-615. doi: 10.1158/2643-3230.BCD-21-0043. eCollection 2021 Nov. Blood Cancer Discov. 2021. PMID: 34778800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources